Homburger houses a broad offering which often advises on cross-border merger control, financing, and patent enforcement mandates. The team notably assists Novartis, Biocorp Holding, and Catalent. Daniel Häusermann stands out due to his broad experience in equity capital markets transactions, and both public and private M&A, while Andri Hess often assists clients with patent litigation and contractual IP issues. Richard Stäuber is well-known for his vast knowledge of merger control and competition investigation issues, with a strong focus on distribution arrangements.
L’éditorial du Legal 500
- Profil
Clients clés
- Catalent
- Novartis
- Roche
- ADC Therapeutics
- Santhera
- Biocorp
- Addex Therapeutics
- Sonic Healthcare
- Sandoz
- Eli Lilly
Points forts
- Representing Catalent in Swiss merger control proceedings related to its USD 16.5 bn acquisition by Novo Holdings.
- Advised Novartis on the divestment of Life Science Park Rhine Valley to GETEC.
- Representing Novartis in enforcing patents against generic JADENU (deferasirox) products.
Avocats
Les grands avocats du marché
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Responsable de la pratique
Daniel Häusermann; Andri Hess; Richard Stäuber